Mebendazole
Information
- Drug Name
- Mebendazole
- Description
- Entry(CIViC)
CIViC
[No Data.]
Annotation
| Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
|---|---|---|---|---|---|---|
| Mebendazole (an anthelmintic drug) seems to act th... | BCL2 | BCL2 UNDEREXPRESSION | Sensitivity | true | MMMP | detail |
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00116493 | Completed | Phase 3 | Severe Anemia Treatment Trials, Pakistan | April 2004 | May 2007 |
| NCT01050452 | Completed | N/A | Safety and Efficacy of Drug Combinations Against Trichuris Trichiura | October 2007 | August 2009 |
| NCT01173562 | Completed | Phase 3 | A Safety Study of Mebendazole in Children 2 to 10 Years of Age | February 2010 | March 2010 |
| NCT01314937 | Completed | Phase 4 | The Effect of a Deworming Intervention to Improve Early Childhood Growth and Development in Resource-poor Areas | September 2011 | July 2013 |
| NCT01379326 | Completed | Phase 4 | Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2 | December 2011 | December 2012 |
| NCT01729260 | Completed | Phase 1 | Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide | April 4, 2013 | April 16, 2021 |
| NCT02034162 | Completed | Phase 3 | A Study to Assess the Efficacy and Safety of Mebendazole for the Treatment of Helminth Infections in Pediatric Participants | December 2014 | September 2015 |
| NCT02385058 | Completed | Phase 4 | Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population | October 2005 | January 2006 |
| NCT02644291 | Completed | Phase 1 | Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors | May 2016 | June 9, 2022 |
| NCT03278431 | Completed | Phase 4 | Triple Combinations Against Hookworm Infections in Lao | September 27, 2017 | December 1, 2017 |
| NCT03995680 | Completed | Phase 2 | Efficacy and Safety of a New Chewable Versus the Swallowable Tablet of Mebendazole Against Hookworm | July 12, 2019 | October 9, 2019 |
| NCT06335160 | Not yet recruiting | N/A | Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine | April 2024 | May 2025 |
| NCT01837862 | Recruiting | Phase 1/Phase 2 | A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas | October 22, 2013 | April 2025 |
| NCT03925662 | Recruiting | Phase 3 | Mebendazole as Adjuvant Treatment for Colon Cancer | April 1, 2019 | December 2028 |
| NCT04443049 | Unknown status | N/A | To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma. | July 10, 2020 | June 19, 2022 |
| NCT03261596 | Withdrawn | Phase 4 | Mebendazole Study Against Hookworm Infections in Children and Adolescents in Ghana | September 2017 | December 2017 |